PainReform Ltd
General ticker "PRFX" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $9.9M
PainReform Ltd does not follow the US Stock Market performance with the rate: -41.4%.
Estimated limits based on current volatility of 39.0%: low 3.70$, high 8.43$
Factors to consider:
- Current price 77.7% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [20.00$, 70.27$]
- 2024-12-30 to 2025-12-30 estimated range: [11.97$, 38.50$]
Financial Metrics affecting the PRFX estimates:
- Negative: Non-GAAP EPS, $ of -7.25 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -33.12 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
- Negative: Interest expense per share, $ of 1.76 > 0.74
Short-term PRFX quotes
Long-term PRFX plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $0.00MM | $0.09MM | $0.00MM |
Operating Expenses | $7.21MM | $8.96MM | $9.58MM |
Operating Income | $-7.21MM | $-8.87MM | $-9.58MM |
Non-Operating Income | $-0.03MM | $0.09MM | $0.25MM |
Interest Expense | $0.01MM | $0.06MM | $0.38MM |
R&D Expense | $2.86MM | $4.42MM | $6.04MM |
Income(Loss) | $-7.24MM | $-8.78MM | $-9.34MM |
Taxes | $0.01MM | $0.01MM | $0.01MM |
Profit(Loss) | $-7.25MM | $-8.79MM | $-9.34MM |
Stockholders Equity | $18.08MM | $11.02MM | $7.24MM |
Inventory | $2.23MM | $7.82MM | $0.00MM |
Assets | $19.07MM | $12.33MM | $9.93MM |
Operating Cash Flow | $-6.55MM | $-6.46MM | $-6.68MM |
Capital expenditure | $0.05MM | $0.01MM | $0.01MM |
Investing Cash Flow | $-0.05MM | $-6.01MM | $5.99MM |
Financing Cash Flow | $7.48MM | $0.00MM | $4.62MM |
Earnings Per Share* | $-7.38 | $-8.25 | $-42.86 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.